论文部分内容阅读
目的探讨肝癌介入化疗患者发生医院感染的临床特征及预防对策,为临床治疗提供参考依据。方法选择2014年8月-2015年7月于医院行介入化疗的肝癌患者208例,制定调查表,对发生医院感染患者的临床资料进行调查分析,数据采用SPSS 19.0软件进行统计分析。结果 208例肝癌介入化疗患者中发生医院感染17例,感染率8.17%;感染部位以肺部、腹部感染为主,分别占35.29%、23.53%;17例医院感染患者中共检出31株病原菌,以大肠埃希菌为主,共10株占32.25%。结论临床上针对肝癌介入化疗的医院感染易感患者,医师与护理人员应采取积极的预防对策,以减少医院感染的发生率。
Objective To investigate the clinical characteristics and preventive strategies of nosocomial infection in patients with hepatocellular carcinoma after interventional chemotherapy and provide reference for clinical treatment. Methods 208 patients with hepatocellular carcinoma who received chemotherapy from August 2014 to July 2015 were enrolled. A questionnaire was drawn to investigate the clinical data of patients with nosocomial infections. The data were analyzed by SPSS 19.0 software. Results In the 208 cases of HCC, 17 cases were hospitalized with nosocomial infection, the infection rate was 8.17%. The main infection areas were lung and abdominal infections, accounting for 35.29% and 23.53% respectively. Thirty-one pathogenic bacteria were detected in 17 cases of nosocomial infection, Escherichia coli-based, a total of 10 strains accounted for 32.25%. Conclusions In order to reduce the incidence of nosocomial infections, physicians and nurses should take active precautionary measures against those susceptible to HCC in hospital infection.